SCHEMBL2492372

SCHEMBL2492372

NCCOC(c1ccccc1F)(c1ccccc1F)c1ccccc1F

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 2/20 0.57
TAAR1 Q96RJ0 2/20 0.38
KDM4E B2RXH2 2/20 0.38
KCNN4 O15554 5/20 0.37
IDO1 P14902 3/20 0.35
MEN1 O00255 1/20 0.34
TRPM2 O94759 1/20 0.34
ALDH1A1 P00352 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
THRB P10828 1/20 0.34
HPGD P15428 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
ALOX12 P18054 1/20 0.34
MAPK1 P28482 1/20 0.34
KMT2A Q03164 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
KCNE1 P15382 1/20 0.33
KCNQ1 P51787 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2492907 0.89 KIF11 (0.70) KIF11TAAR1KDM4EKCNN4MEN1
SCHEMBL2490788 0.89 KIF11 (0.44) KIF11TAAR1KCNN4IDO1TDP1
SCHEMBL2493496 0.82 KIF11 (0.37) KIF11KCNN4IDO1ALDH1A1TDP1
SCHEMBL2489496 0.79 KIF11 (0.35) KIF11KDM4EKCNN4MEN1ALDH1A1
SCHEMBL2489578 0.79 KIF11 (0.56) KIF11KCNN4ALOX15TSHRKCNE1
SCHEMBL2490388 0.78 KIF11 (0.55) KIF11TAAR1KDM4EMEN1TRPM2
SCHEMBL2490799 0.76 KIF11 (0.52) KIF11TAAR1KDM4EIDO1ALDH1A1
SCHEMBL2491322 0.73 KIF11 (0.49) KIF11KCNN4ALDH1A1ALOX15TSHR
SCHEMBL2492363 0.72 KIF11 (1.00) KIF11TAAR1KDM4EKCNN4MEN1
SCHEMBL2492412 0.71 KIF11 (0.46) KIF11KCNN4ALOX15TSHRKCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH KIF11 4556/4885TAAR1 225/4885KDM4E 2772/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 KIF11 4605/4885TAAR1 194/4885KDM4E 3096/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R KIF11 4611/4885TAAR1 225/4885KDM4E 3125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.